---
schema_version: "secwatch.filing_event.v1"
accession: "0001655759-24-000101"
form_type: "8-K"
ticker: "ARVN"
cik: "0001655759"
company_name: "ARVINAS, INC."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:28:42.536056+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Arvinas appoints Andrew Saik as CFO, effective June 24, 2024

## Summary
- Andrew Saik, former Intercept Pharmaceuticals CFO, named permanent CFO at Arvinas.
- Base salary of $525,000; annual bonus target of 45% of base salary.
- Granted 94,418 options and 61,409 RSUs, both vesting over four years.
- Randy Teel, Ph.D., who served as interim CFO, returns to chief business officer role.

## SEC filing metadata
- accession: 0001655759-24-000101
- form_type: 8-K
- ticker: ARVN
- cik: 0001655759
- company_name: ARVINAS, INC.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000101/0001655759-24-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1655759/000165575924000101/arvn-20240622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001655759-24-000101
- JSON: https://secwatch.observer/filing/0001655759-24-000101.json
- Plain text: https://secwatch.observer/filing/0001655759-24-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.